Albany Molecular Research, Inc. Announces Drug Discovery Research Collaboration With Bristol-Myers Squibb Company

ALBANY, N.Y.--(BUSINESS WIRE)--Albany Molecular Research, Inc. (NASDAQ: AMRI) has entered into a two-year natural products-based drug discovery collaboration with Bristol-Myers Squibb Company (NYSE: BMY).